The last two decades have witnessed the steady growth of the protein drug market. As original recombinant products come off patent, generics/ biosimilars are also beginning to be manufactured. The ...

The emergence of advanced therapy medicinal products (ATMPs) including cell therapies, has led to many bioanalytical ...

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer The two droplet digital polymerase chain reaction assays reported VAF values very close to the ...

The gap between lab measurements and real-world applications can lead to suboptimal socket selection and hidden quality risks ...

DUBLIN--(BUSINESS WIRE)--The "Method Development and Validation for Assays Supporting Testing of Biologics" conference has been added to ResearchAndMarkets.com's offering. This 2-day seminar is ...

Guidelines advocate molecular profiling in the evaluation of advanced non–small-cell lung cancer (NSCLC) and support the use of plasma circulating tumor DNA (ctDNA)-based profiling for patients with ...

Recombinant antibodies and rigorous validation standards are advancing cancer biomarker research, bridging the gap between early discovery and clinical translation. At every step of the biomarker ...

DUBLIN--(BUSINESS WIRE)--The "Method Development and Validation for Assays Supporting Testing of Biologics" conference has been added to ResearchAndMarkets.com's offering. Biologics continue to be a ...

CEO Sujal Patel highlighted progress in advancing Nautilus' proteome analysis platform, focusing on targeted proteoform detection and broadscale discovery. He emphasized the tau proteoform assay's ...

Leading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full Diagnostic Assay Platform The Company had previously announced the commencement of commercial ...